Clearpoint Neuro Inc
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser cat… Read more
Market Cap & Net Worth: Clearpoint Neuro Inc (CLPT)
Clearpoint Neuro Inc (NASDAQ:CLPT) has a market capitalization of $331.99 Million ($331.99 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13013 globally and #5467 in its home market, demonstrating a -3.29% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Clearpoint Neuro Inc's stock price $11.16 by its total outstanding shares 29748308 (29.75 Million).
Clearpoint Neuro Inc Market Cap History: 2015 to 2026
Clearpoint Neuro Inc's market capitalization history from 2015 to 2026. Data shows change from $452.17 Million to $331.99 Million (-7.09% CAGR).
Index Memberships
Clearpoint Neuro Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.01% | #353 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1271 of 3165 |
Weight: Clearpoint Neuro Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Clearpoint Neuro Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Clearpoint Neuro Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
14.58x
Clearpoint Neuro Inc's market cap is 14.58 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $452.17 Million | $4.59 Million | -$8.45 Million | 98.42x | N/A |
| 2016 | $101.14 Million | $5.75 Million | -$8.07 Million | 17.59x | N/A |
| 2017 | $81.81 Million | $7.38 Million | -$7.17 Million | 11.09x | N/A |
| 2018 | $46.70 Million | $7.35 Million | -$6.16 Million | 6.35x | N/A |
| 2019 | $142.79 Million | $11.22 Million | -$5.54 Million | 12.73x | N/A |
| 2020 | $472.70 Million | $12.83 Million | -$6.78 Million | 36.85x | N/A |
| 2021 | $333.78 Million | $16.30 Million | -$14.41 Million | 20.48x | N/A |
| 2022 | $251.97 Million | $20.55 Million | -$16.43 Million | 12.26x | N/A |
| 2023 | $201.99 Million | $23.95 Million | -$22.09 Million | 8.43x | N/A |
| 2024 | $457.53 Million | $31.39 Million | -$18.91 Million | 14.58x | N/A |
Competitor Companies of CLPT by Market Capitalization
Companies near Clearpoint Neuro Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Clearpoint Neuro Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Clearpoint Neuro Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Clearpoint Neuro Inc's market cap moved from $452.17 Million to $ 331.99 Million, with a yearly change of -7.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $331.99 Million | -18.42% |
| 2025 | $406.96 Million | -11.05% |
| 2024 | $457.53 Million | +126.51% |
| 2023 | $201.99 Million | -19.83% |
| 2022 | $251.97 Million | -24.51% |
| 2021 | $333.78 Million | -29.39% |
| 2020 | $472.70 Million | +231.04% |
| 2019 | $142.79 Million | +205.73% |
| 2018 | $46.70 Million | -42.91% |
| 2017 | $81.81 Million | -19.12% |
| 2016 | $101.14 Million | -77.63% |
| 2015 | $452.17 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Clearpoint Neuro Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $331.99 Million USD |
| MoneyControl | $331.99 Million USD |
| MarketWatch | $331.99 Million USD |
| marketcap.company | $331.99 Million USD |
| Reuters | $331.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.